CLSD Quote, Trading Chart, Clearside Biomedical Inc.
home / stock / clsd / clsd quote
$3.25 Last:
-6.88% Change Percent:
$3.49 Open:
$3.25 Previous Close:
$3.56 High:
$3.18 Low:
490,951 Volume:
02/25/2021 04:55:23 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-02-25 | 3.49 | 3.25 | 3.56 | 3.18 | 490,951 |
| 2021-02-24 | 3.53 | 3.49 | 3.71 | 3.46 | 188,242 |
| 2021-02-23 | 3.75 | 3.5 | 3.85 | 3.03 | 814,516 |
| 2021-02-22 | 3.93 | 3.8 | 4.25 | 3.8 | 506,118 |
| 2021-02-19 | 3.48 | 3.85 | 4.03 | 3.4255 | 679,894 |
| 2021-02-18 | 3.62 | 3.47 | 3.63 | 3.3 | 410,346 |
| 2021-02-17 | 3.86 | 3.58 | 3.86 | 3.54 | 376,600 |
| 2021-02-16 | 3.85 | 3.86 | 4.2 | 3.81 | 444,384 |
| 2021-02-15 | 3.9 | 3.83 | 3.91 | 3.75 | 309,018 |
| 2021-02-12 | 3.9 | 3.83 | 3.91 | 3.75 | 308,912 |
| 2021-02-11 | 4.25 | 3.86 | 4.34 | 3.7 | 866,482 |
| 2021-02-10 | 4 | 4.25 | 4.53 | 3.823 | 1,395,349 |
| 2021-02-09 | 3.84 | 3.89 | 4.01 | 3.77 | 603,526 |
| 2021-02-08 | 3.47 | 3.82 | 4.0573 | 3.4 | 1,016,103 |
| 2021-02-05 | 3.5 | 3.4 | 3.55 | 3.26 | 389,095 |
| 2021-02-04 | 3.59 | 3.5 | 3.59 | 3.38 | 254,744 |
| 2021-02-03 | 3.55 | 3.51 | 3.59 | 3.35 | 503,696 |
| 2021-02-02 | 3.12 | 3.25 | 3.26 | 3.07 | 430,058 |
| 2021-02-01 | 3.07 | 3.07 | 3.1778 | 2.97 | 788,599 |
| 2021-01-29 | 3.31 | 3.13 | 3.44 | 3.11 | 424,592 |
Clearside Biomedical Inc. Company Name:
CLSD Stock Symbol:
NASDAQ Market:
Clearside Biomedical Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
- Proprietary suprachoroidal injection platform demonstrates broad applicability across multiple retinal disorders - - CLS-AX will also be featured at the upcoming virtual Angiogenesis, Exudation, and Degeneration 2021 conference on February 13, 2021 - ALPHARETTA, ...
-
ALPHARETTA, Ga., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that the first p...
-
ALPHARETTA, Ga., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that it has ente...